A pro-life pregnancy help center (PHC) in Baltimore has won another legal victory in its fight against a city ordinance.
Imagine you live in San Francisco and decide to move to Flagstaff, Arizona. You meet a friend one evening at a social event, and during your conversation, mention your intention to move. Your friend expresses horror at the idea (even though he has never been). “But why,” he says “would you choose to live in Arizona? It’s hot and filled with deserts.”
In 2014, Minnesota became the most recent of a handful of states that provide state funding for all types of stem cell research, including human embryonic stem cell research. The law provides for 10 years of funding with $4.5 million approved for the first year and $4.35 million each year thereafter.
In 2002, the Netherlands became the first country in the world to decriminalize euthanasia and physician-assisted suicide (PAS) for patients who meet criteria set forth by the law, such as that they endure “unbearable” suffering with “no prospect of improvement.” Now the Dutch government is pushing to expand eligibility to include individuals who have no medical condition but nevertheless feel that their life is completed.
Those watching the nation’s capital earlier this year witnessed three important events bearing on religious freedom and rights of conscience in the abortion debate.
In the years leading up to and following the Supreme Court’s 1973 decision in Roe v. Wade legalizing abortion nationwide, the federal government—primarily Congress—has enacted various measures governing the availability of federal funds for abortion and related services.
The Maryland Stem Cell Research Fund (MSCRF) has awarded two rounds of grants since the Charlotte Lozier Institute last analyzed the Fund’s pattern of grant making for stem cell research, in the fall of 2013. That study found that since MSCRF first began awarding grants in 2007, its pattern of giving shifted over the years from strongly favoring projects focusing on ethically contentious human embryonic stem cell research (hESCR) to projects focusing on ethically non-contentious adult stem cells and other non-embryonic stem cell research.
On October 7, the Charlotte Lozier Institute (CLI) filed two separate comments to the Department of Health and Human Services regarding its proposed rule on entities qualifying for the government’s Title X family planning funds.
The treatment of women seeking abortions has arisen several times during the ongoing election cycle. Some abortion advocates claim that pro-lifers want to punish women seeking abortion. They argue that women were punished for having abortions before Roe v. Wade was decided by the Supreme Court in 1973, and that if Roe is repealed women will once again be subject to punishment.
On October 5, the District of Columbia’s Committee on Health and Human Services (HHS) will mark-up and vote on a bill to legalize physician-assisted suicide. The so-called “Death with Dignity Act” (Bill 21-0038) would permit D.C. adult residents to request and be prescribed drugs to end their lives, if they are given a prognosis of six months or less to live. Last year, during a hearing on the legislation, the Director of D.C.’s Department of Health testified in staunch opposition as the executive witness, stating that the bill would “catapult the District into unchartered territories.”
Last Thursday, the March for Life hosted a Capitol Hill policy briefing to announce their theme for 2017: “The Power of One.” The event also highlighted the importance of the Hyde Amendment, featuring Charlotte Lozier Institute (CLI) senior policy analyst, Genevieve Plaster, M.A. and CLI associate scholar, Michael J. New, Ph.D. who provided policy background and explained the law’s measurable impact over the past 40 years.